Hermes Pharma presents poster on hot melt coating for immediate-release orally disintegrating granules

Published: 15-Apr-2016 Featured companies: Hermes Pharma GmbH
Manufacturing

Poster from the 10th World Meeting on Pharmaceutics, Biopharmaceutics & Pharmaceutical Technology now ready for download


Hermes Pharma attended the 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology which took place in, Glasgow, UK from 4-7 April 2016. The conference and its accompanying exhibition take place every second year and provide a cross-disciplinary platform for pharmaceutical scientists working in all fields of drug product development in industry.

The company showcased its latest work on hot melt coating technology to an international and very versatile audience. The poster - Hot Melt Coated Immediate Release, Taste-masked Paracetamol and Caffeine Orally Disintegrating Granules - can be downloaded here.

Featured companies

HERMES PHARMA is the leading expert in developing and manufacturing user-friendly oral dosage forms. As a CDMO, we offer customized services along the entire pharmaceutical...
See more

You may also like

Manufacturing

Hermes invests $23.6m in oral dosage form capabilities

Read more
The company has revealed it is set to invest $23.6m to bolster production and storage capacity with greater operational efficiency to meet the demand for oral dosage forms

Trending Articles

  1. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  4. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles
  5. Pharmaceutics International bolsters its prefilled syringe production capabilities The aseptic and oral dosage CDMO has invested USD $3.6m into advanced labelling, fill/finish and automated visual inspection technologies at its Hunt Valley site in Maryland, US

Relevant companies

See more

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

Hermes invests $23.6m in oral dosage form capabilities

The company has revealed it is set to invest $23.6m to bolster production and storage capacity with greater operational efficiency to meet the demand for oral dosage forms
Manufacturing

Manufacturing Chemist LIVE announces NEPIC as an event partner

NEPIC members are invited to attend or exhibit at this year's event at a discounted rate.
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Incorporating quality by design (QbD) into pharmaceutical manufacturing

The pharmaceutical industry has always maintained a focus on quality; the risks are simply too high not to!
Manufacturing

Carinthia Innovation and Research Award conferred on Hermes Pharma

Company received the award for its research into hot melt coating (HMC), a novel granulation technology
Manufacturing

Research project aims to improve orodispersible medicines

New taste-masking technologies could increase patient compliance and improve production processes
Manufacturing

Samsung Biologics bags $668 manufacturing deal with European pharmaceutical company

The CDMO will be responsible for the manufacture of the client's biopharmaceuticals until December 2031
Manufacturing

CDMO GBI Biomanufacturing expands US drug product services with aseptic fill/finish capabilities

Its Florida site will now be able to support biopharma clients from clinical trials to commercialisation with a dual manual/automated fill/finish approach
Subscribe now